At baseline, there was no significant difference between the two groups in terms of patient demographics, risk factors for cardiovascular disease (hypertension, diabetes mellitus, smoking status, dyslipidemia, obesity or family history), hsCRP or echocardiographic parameters. Table 1 shows medications administered by both groups at baseline and after 3 months.